Project CBD
MARCH 21, 2023
All but two of the 45 respondents said they’d consider cannabis as a treatment, with 29 seeking help for sleep disturbances, 27 for emotional complaints, 25 for functional disturbances, and nine for pain. Despite all this, there is a potential biological rationale for the treatment of tinnitus with cannabinoids, the authors explain.
Veriheal
MARCH 20, 2023
Using psilocybin in small doses, or microdosing, has been shown to aid in the treatment of various mental health issues, including anxiety, depression, PTSD, and obsessive-compulsive disorder. In 2006, the first research paper by Johns Hopkins was published on the positive long-term impact of using psilocybin in a therapeutic study.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Otherside Farms
JANUARY 23, 2019
Differential effects of repeated low dose treatment with the cannabinoid agonist WIN 55,212-2 in experimental models of bone cancer pain and neuropathic pain. Antitumor Activity of Plant Cannabinoids with Emphasis on the Effect of Cannabidiol on Human Breast Carcinoma (full – 2006). abst – 2006). CANCER – BONE.
Weedistry
MARCH 7, 2019
A team of Spanish scientists led by Manuel Guzman conducted the first clinical trial assessing the antitumoral action of THC on human beings. The results were published in 2006 in the British Journal of Pharmacology : THC treatment was associated with significantly reduced tumor cell proliferation in every test subject.
Healer
DECEMBER 17, 2021
Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. . Journal of clinical psychopharmacology 41.5
Greencamp
AUGUST 16, 2018
The first study I will reference is from 2006, conducted on mice. Kim K, Moore DH, Makriyannis A, Abood ME; AM1241, a cannabinoid CB2 receptor selective compound, delays disease progression in a mouse model of amyotrophic lateral sclerosis; European Journal of Pharmacology, August 2006, Pages 100-105.
Healer
DECEMBER 17, 2021
Drug interactions reported in the scientific literature most often occur at very high doses used in clinical trials of epilepsy and other conditions.[1]. Based on my clinical experience, it is rare for people to experience CBD-drug interactions at doses below 100mg daily. [2]. Journal of clinical psychopharmacology 41.5
Expert insights. Personalized for you.
144 
Let's personalize your content